Adagio Medical Holdings, Inc. (ADGM)
USD 1.14
(2.52%)
USD 1.14
(2.52%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 300 Thousand | 189 Thousand | 270 Thousand | - |
| Cost of Revenue | 1.3 Million | 875 Thousand | 1.15 Million | - |
| Gross Profit | -1 Million | -686 Thousand | -888 Thousand | - |
| Operating Expenses | 26.93 Million | 1 Million | 6.61 Million | 13.53 Thousand |
| Selling, General and Administrative Expenses | 11.53 Million | 1 Million | 6.61 Million | 13.53 Thousand |
| Research and Development Expenses | 15.39 Million | 17.85 Million | 15.35 Million | - |
| Other Expenses | - | 338 Thousand | -40 Thousand | - |
| Cost and Expenses | 28.24 Million | 1 Million | 6.61 Million | 13.53 Thousand |
| Operating Income | -27.94 Million | -1 Million | -6.61 Million | -13.53 Thousand |
| Interest Expense | 1.65 Million | 137 Thousand | - | - |
| Income Tax Expense | - | - | - | - |
| Earnings before Tax | -38.14 Million | 1.06 Million | -6.56 Million | -13.53 Thousand |
| Net Income | -38.14 Million | 1.06 Million | -6.56 Million | -13.53 Thousand |
| Earnings Per Share Basic | -0.16 | 0.06 | -0.34 | -0.00 |
| Earnings Per Share Diluted | -0.16 | 0.06 | -0.34 | -0.00 |
| Weighted Average Shares Outstanding | 13.38 Million | 19.18 Million | 19.18 Million | 19.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 13.38 Million | 19.18 Million | 19.18 Million | 19.18 Million |
| Gross Margin | -3.35 | -3.63 | -3.29 | - |
| EBIT Margin | -91.37 | -16.33 | -24.69 | - |
| Profit Margin | -127.15 | 5.65 | -24.30 | - |
| EBITDA | -27.41 Million | -23.41 Million | -19.6 Million | -13.53 Thousand |
| Earnings Before Tax Margin | -93.14 | -5.34 | -24.50 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 254 Thousand | 26 Thousand | 300 Thousand | 78 Thousand | - | - |
| Cost of Revenue | 682 Thousand | 542 Thousand | 1.3 Million | 334 Thousand | - | - |
| Gross Profit | -428 Thousand | -516 Thousand | -1 Million | -256 Thousand | - | - |
| Operating Expenses | -713.79 Thousand | 611.74 Thousand | 4.75 Million | 2.74 Million | 959.67 Thousand | 78.85 Thousand |
| Selling, General and Administrative Expenses | 3.36 Million | 611.74 Thousand | - | 2.74 Million | 959.67 Thousand | 78.85 Thousand |
| Research and Development Expenses | 2.86 Million | 3.46 Million | - | 1.77 Million | - | - |
| Other Expenses | -713.79 Thousand | -145.85 Thousand | -20 Thousand | 93 Thousand | - | - |
| Cost and Expenses | -713.79 Thousand | 611.74 Thousand | 4.75 Million | 2.74 Million | 959.67 Thousand | 78.85 Thousand |
| Operating Income | 713.79 Thousand | -611.74 Thousand | -4.75 Million | -2.74 Million | -959.67 Thousand | -78.85 Thousand |
| Interest Expense | - | 754 Thousand | 1.65 Million | 577 Thousand | - | - |
| Income Tax Expense | -6.65 Million | -841.75 Thousand | - | -133 Thousand | - | - |
| Earnings before Tax | -713.79 Thousand | -245.84 Thousand | -2.13 Million | -2.22 Million | -455.07 Thousand | 381.51 Thousand |
| Net Income | -713.79 Thousand | -245.84 Thousand | -2.13 Million | -2.22 Million | -455.07 Thousand | 381.51 Thousand |
| Earnings Per Share Basic | -0.05 | -0.03 | - | -0.25 | -0.06 | 0.05 |
| Earnings Per Share Diluted | -0.05 | -0.03 | - | -0.25 | -0.06 | 0.05 |
| Weighted Average Shares Outstanding | 13.38 Million | 7.78 Million | 9.8 Million | 8.79 Million | 7.42 Million | 7.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 13.38 Million | 7.78 Million | 9.8 Million | 8.79 Million | 7.42 Million | 7.42 Million |
| Gross Margin | -1.69 | -19.85 | -3.35 | -3.28 | - | - |
| EBIT Margin | -25.20 | -23.53 | - | -35.19 | - | - |
| Profit Margin | -2.81 | -9.46 | -7.11 | -28.46 | - | - |
| EBITDA | -6.4 Million | -611.74 Thousand | - | -2.74 Million | -959.67 Thousand | -78.85 Thousand |
| Earnings Before Tax Margin | 2.81 | -23.53 | -15.84 | -35.19 | - | - |
CAPMF
GAP
BRYN
4168
KYRI
8088